Disability during the last two years of life. Read more about Disability during the last two years of life.
Fat intake after diagnosis and risk of lethal prostate cancer and all-cause mortality. Read more about Fat intake after diagnosis and risk of lethal prostate cancer and all-cause mortality.
Patient-reported problems after office procedures. Read more about Patient-reported problems after office procedures.
Expanding utilization of intensity-modulated radiotherapy for prostate cancer: soaring costs, dubious benefits: comment on "Comparative effectiveness of intensity-modulated radiotherapy and conventional conformal radiotherapy in the treatment of prostate Read more about Expanding utilization of intensity-modulated radiotherapy for prostate cancer: soaring costs, dubious benefits: comment on "Comparative effectiveness of intensity-modulated radiotherapy and conventional conformal radiotherapy in the treatment of prostate
Cervical cancer screening intervals, 2006 to 2009: moving beyond annual testing. Read more about Cervical cancer screening intervals, 2006 to 2009: moving beyond annual testing.
Five-year downstream outcomes following prostate-specific antigen screening in older men. Read more about Five-year downstream outcomes following prostate-specific antigen screening in older men.
High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study. Read more about High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study.
Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. Read more about Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
Trends in on-label and off-label modafinil use in a nationally representative sample. Read more about Trends in on-label and off-label modafinil use in a nationally representative sample.
Talking about stopping cancer screening-not so easy. Read more about Talking about stopping cancer screening-not so easy.
